SPONSOR
Fox Chase Cancer Center
Total Trials
6
Recruiting
6
Phases
Phase 2
Conditions studied: Gynecologic CancersCare DeliveryGeriatricsGeriatric AssessmentOropharynx CancerBladder CancerUrothelial CarcinomaMuscle-Invasive Bladder CarcinomaMuscle-invasive Bladder Urothelial CarcinomaMetastatic Urothelial Carcinoma
Fox Chase Cancer Center is a clinical research sponsor with 6 registered studies on ClinicalTrials.gov, of which 6 are actively recruiting participants. Research covers conditions including Gynecologic Cancers, Care Delivery, Geriatrics, Geriatric Assessment.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Fox Chase Cancer Center
How many clinical trials has Fox Chase Cancer Center sponsored?
ClinicalMetric currently tracks 6 clinical trials sponsored by Fox Chase Cancer Center, of which 6 are actively recruiting participants. These trials cover conditions including Gynecologic Cancers, Care Delivery, Geriatrics. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Fox Chase Cancer Center research focus on?
Fox Chase Cancer Center clinical trials span Gynecologic Cancers, Care Delivery, Geriatrics, Geriatric Assessment, Oropharynx Cancer, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Fox Chase Cancer Center clinical trial?
To participate in a Fox Chase Cancer Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Fox Chase Cancer Center trials with current recruitment status updated daily.
Clinical Trials by Fox Chase Cancer Center
NCT06904339
Recruiting
Communication About Sexual Health in Gynecologic Cancer
Gynecologic Cancers
NCT06652347
Recruiting
Understanding the Preferences and Views of Older Adults on the Use of Geriatric and Objective Functional Assessments for Cancer Treatment Planning.
Care Delivery
NCT05800574 Phase 2
Recruiting
Lymphoscintigraphy Directed Elective Neck Radiation for p16+ Favorable Risk Oropharynx Cancer
Oropharynx Cancer
NCT07908979 Phase 2
Recruiting
Risk-Enabled Therapy After Initiating EV/Pembro for Bladder Cancer
Bladder Cancer
NCT07221942 Phase 2
Recruiting
Pembrolizumab Maintenance After Enfortumab Vedotin (EV)/Pembro Induction in Front-Line Metastatic Urothelial Carcinoma
Metastatic Urothelial Carcinoma
NCT06782581
Recruiting
CARE Study: Cancer, Asian Americans, and Relationship Enrichment
Neoplasm
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology